Expression of A(2B) adenosine receptors in human lymphocytes: Their role in T cell activation

Journal of Cell Science

Volumn 112, Issue 4, 1999, Pages 491-502

  Mirabet, Maribel ^a   Herrera, Carolina ^a   Cordero, Oscar J ^b   Mallol, Josefa ^a   Lluis, Carmen ^a   Franco, Rafael ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE

Author keywords

Adenosine receptor; Antipeptide antibody; T cell activation

Indexed keywords

ADENOSINE; ADENOSINE A2 RECEPTOR; ADENYLATE CYCLASE; CYCLIC AMP; PHYTOHEMAGGLUTININ; POLYCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; BLOOD; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOCYTOCHEMISTRY; LYMPHOCYTE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALIA;

EID: 0033043321     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Antonysamy, M. A., Moticka, E. J. and Ramkumar, V. (1995). Adenosine acts as an endogenous modulator of IL-2 dependent proliferation of cytotoxic T lymphocytes. J. Immunol. 155, 2813-2821.
2. Apasov, S. G., Koshiba, M., Chused, T. M. and Sitkovsky, M. V. (1997). Effects of extracellular ATP and adenosine on different thymocyte subsets: Possible role of ATP-gated channels and G protein-coupled purinergic receptor. J. Immunol. 158, 5095-5105.
3. Boyum, A. (1968). Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Invest. 21, 51-62.
4. Chouaib, S., Robb, R. J., Welte, K. and DuPont, B. (1987) Analysis of prostaglandin E2 effect on T lymphocyte activation. Abrogation of prostaglandin E2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetate. J. Clin. Invest. 80, 11-25.
5. Ciruela, F., Saura, C., Canela, E. I., Mallol, J., Lluis, C. and Franco, R. (1996). Adenosine deaminase affects ligand-induced signalling by interacting with adenosine receptors. FEBS Lett. 380, 219-223.
6. Daly, J. W., Butts-Lamb, P. and Padgett, W. (1983). Subclasses of adenosine receptors in the central nervous system: interactions with caffeine and related methylxanthines. Cell Mol. Neurobiol. 3, 69-80.
7. Dinjens, W. N. M., van Doorn, R., van Laarhoven, J. P. R. M., Roos, R., Zeijlemaker, W. P. and de Bruijn, C. H. M. M. (1986). Adenosine receptors on human T lymphocytes and human thymocytes. Adv. Exp. Med. Biol. 195, 1-6.
8. Dos Reis, G. A., Nóbrega, A. F. and Paes de Carvalho, R. (1986). Purinergic modulation of T-lymphocyte activation: differential susceptibility of distinct activation steps and correlation with intracellular 3′-5′-cyclic adenosine monophosphate accumulation. Cell. Immunol. 101, 213-231.
9. Franco, R., Valenzuela, A., Lluis, C. and Blanco, J. (1998). Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes. Immunol. Rev. 161, 27-42.
10. Fredholm, B. B., Ahlberg, S., Altiok, N., Gerwins, P., Parkinson, F., van der Ploegh, I., Kvanta, A., Nordstedt, C. and Dunwiddie, T. (1991). Interactions between adenosine receptors and other membrane receptors. In Role of Adenosine and Adenine Nucleotides in the Biological System (ed. S. Imai and K. Nakazawa), pp. 173-182. Elsevier Science, Amsterdam.
11. Fredholm, B. B. (1995). Adenosine, adenosine receptors and the actions of caffeine. Pharmacol. Taxicol. 76, 93-101.
12. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
13. Hershfield, M. S. and Mitchell, B. S. (1989). Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In The Metabolic and Molecular Bases of Inherited Disease, 7th edition (ed. C. R. Scriver, A. L. Beaudet, W. S. Sly and D. Valle), pp. 1725-1768. McGraw-Hill, New York.
14. 2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90, 1600-1610.
15. Kelley, L. L., Blackmore, P. F., Graber, S. E. and Stewart S. T. (1990) Agents that raise cAMP in human T lymphocytes release an intracellular pool of calcium in the absence of inositol phosphate production. J. Biol. Chem. 265, 17657-17664.
16. Kitagawa, T. and Aikawa, T. (1976). Enzyme coupled immunoassay of insulin using a novel coupling reagent. J. Biochem. 79, 233-236.
17. Kyte, J. and Doolitte, R. F. (1982). A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105-132.
18. 3 adenosine receptor with widespread tissue distribution. Mol. Pharmacol. 44, 524-532.
19. Linden, J. (1994). Purinergic systems. In Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 5th edition (ed. G. J. Siegel), pp. 401-416. Raven Press, New York.
20. Londos, C., Cooper, D. M. F. and Wolff, J. (1980). Subclasses of external adenosine receptors. Proc. Nat. Acad. Sci. USA 77, 2551-2554.
21. Marone, G., Plaut, M. and Lichtenstein, L. M. (1978). Characterization of a specific adenosine receptor on human lymphocytes. J. Immunol. 11, 2153-2159.
22. Martín, M., Huguet, J., Centelles, J. J. and Franco, R. (1995). Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex: Possible role of adenosine deaminase as costimulatory molecule. J. Immunol. 155, 4630-4643.
23. 2b adenosine receptors. Br. J. Pharmacol. 122, 1075-1082.
24. 2b receptor from human brain. Biochem. Biophys. Res. Commun. 187, 86-93.
25. Rivkees, S. A., Lasbury, M. E. and Barbhaiya, H. (1995). Identification of domains of the human A1 adenosine receptor that are important for binding receptor subtype-selective ligands using chimeric A1/A2A adenosine receptors. J. Biol. Chem. 270, 20485-20490.
26. Resta, R. and Thompson, L. F. (1997). SCID: the role of adenosine deaminase deficiency. Immunol. Today 18, 371-374.
27. 3 adenosine receptor. Proc. Nat. Acad. Sci USA 90, 10365-10369.
28. Stiles, G. L. (1992). Adenosine receptors. J. Biol. Chem. 267, 6451-6454.
29. 1 adenosine receptors in pig brain cortical membranes. J. Neurochem. 66, 1675-1682.
30. 1 adenosine receptors internalize together following agonist-induced receptor desensitization. J. Biol. Chem. 273, 17610-17617.
31. Schubert, P., Rudolphi, K. A., Fredholm, B. B. and Nakamura, Y. (1994). Modulation of nerve and glial function by adenosine. Role in the development of ischemic damage. Int. J. Biochem. 26, 1227-1236.
32. Schultz, L. A., Kammer, G. M. and Rudolph, S. A. (1988). Characterization of the human T lymphocyte adenosine receptor: comparison of normal and systemic lupus erythematosus cells. FASEB J. 2, 244-250.
33. Sorensen, K. and Brodbeck, U. (1986). A sensitive protein assay using microliter plates. Experientia 42, 161-162.
34. 2-adenosine receptor subtype. Mol. Endocrinol. 6, 384-393.
35. Tanaka, T., Slamon, D. J. and Cline, M. J. (1985). Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens. Proc. Nat. Acad. Sci. USA 82, 3400-3404.
36. Tucker, A. L. and Linden, J. (1993). Cloned receptors and cardiovascular responses to adenosine. Cardiovasc. Res. 27, 62-67.
37. Van Calker, D., Müller, M. and Hamprecht, B. (1979). Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33, 999-1005.
38. Windscheif, U. (1996). Purinoceptors: From history to recent progress. A review. J. Pharm. Pharmacol. 48, 993-1011.
39. Wolberg, G., Zimmerman, T. P., Hiemstra, K., Winston, M. and Chi, L.-C. (1975). Adenosine inhibition of lymphocyte-mediated cytolysis: Possible role of cyclic adenosine monophosphate. Science 187, 957-959.
40. 2B adenosine receptor expression in macrophages. A mechanism of macrophage deactivation. J. Immunol. (in press).
41. 3 adenosine receptor. Proc. Nat. Acad. Sci. USA 89, 7432-7436.